Cargando…

Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer

Malignant biliary obstruction generally results from primary malignancies of the pancreatic head, bile duct, gallbladder, liver, and ampulla of Vater. Metastatic lesions from other primaries to these organs or nearby lymph nodes are rarer causes of biliary obstruction. The most common primaries incl...

Descripción completa

Detalles Bibliográficos
Autor principal: Okamoto, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968522/
https://www.ncbi.nlm.nih.gov/pubmed/35431494
http://dx.doi.org/10.3748/wjg.v28.i10.985
_version_ 1784679063393140736
author Okamoto, Takeshi
author_facet Okamoto, Takeshi
author_sort Okamoto, Takeshi
collection PubMed
description Malignant biliary obstruction generally results from primary malignancies of the pancreatic head, bile duct, gallbladder, liver, and ampulla of Vater. Metastatic lesions from other primaries to these organs or nearby lymph nodes are rarer causes of biliary obstruction. The most common primaries include renal cancer, lung cancer, gastric cancer, colorectal cancer, breast cancer, lymphoma, and melanoma. They may be difficult to differentiate from primary hepato-pancreato-biliary cancer based on imaging studies, or even on biopsy. There is also no consensus on the optimal method of treatment, including the feasibility and effectiveness of endoscopic intervention or surgery. A thorough review of the literature on pancreato-biliary metastases and malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer is presented. The diagnostic modality and clinical characteristics may differ significantly depending on the type of primary cancer. Different primaries also cause malignant biliary obstruction in different ways, including direct invasion, pancreatic or biliary metastasis, hilar lymph node metastasis, liver metastasis, and peritoneal carcinomatosis. Metastasectomy may hold promise for some types of pancreato-biliary metastases. This review aims to elucidate the current knowledge in this area, which has received sparse attention in the past. The aging population, advances in diagnostic imaging, and improved treatment options may lead to an increase in these rare occurrences going forward.
format Online
Article
Text
id pubmed-8968522
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-89685222022-04-14 Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer Okamoto, Takeshi World J Gastroenterol Review Malignant biliary obstruction generally results from primary malignancies of the pancreatic head, bile duct, gallbladder, liver, and ampulla of Vater. Metastatic lesions from other primaries to these organs or nearby lymph nodes are rarer causes of biliary obstruction. The most common primaries include renal cancer, lung cancer, gastric cancer, colorectal cancer, breast cancer, lymphoma, and melanoma. They may be difficult to differentiate from primary hepato-pancreato-biliary cancer based on imaging studies, or even on biopsy. There is also no consensus on the optimal method of treatment, including the feasibility and effectiveness of endoscopic intervention or surgery. A thorough review of the literature on pancreato-biliary metastases and malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer is presented. The diagnostic modality and clinical characteristics may differ significantly depending on the type of primary cancer. Different primaries also cause malignant biliary obstruction in different ways, including direct invasion, pancreatic or biliary metastasis, hilar lymph node metastasis, liver metastasis, and peritoneal carcinomatosis. Metastasectomy may hold promise for some types of pancreato-biliary metastases. This review aims to elucidate the current knowledge in this area, which has received sparse attention in the past. The aging population, advances in diagnostic imaging, and improved treatment options may lead to an increase in these rare occurrences going forward. Baishideng Publishing Group Inc 2022-03-14 2022-03-14 /pmc/articles/PMC8968522/ /pubmed/35431494 http://dx.doi.org/10.3748/wjg.v28.i10.985 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Review
Okamoto, Takeshi
Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer
title Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer
title_full Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer
title_fullStr Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer
title_full_unstemmed Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer
title_short Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer
title_sort malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968522/
https://www.ncbi.nlm.nih.gov/pubmed/35431494
http://dx.doi.org/10.3748/wjg.v28.i10.985
work_keys_str_mv AT okamototakeshi malignantbiliaryobstructionduetometastaticnonhepatopancreatobiliarycancer